10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,565,250 | -28.8% | 183,400 | -3.6% | 0.01% | -14.3% |
| Q2 2023 | $10,626,352 | +15.4% | 190,300 | +15.3% | 0.01% | +16.7% |
| Q1 2023 | $9,210,929 | +37.7% | 165,100 | -10.1% | 0.01% | +20.0% |
| Q4 2022 | $6,690,384 | +17.2% | 183,600 | -8.4% | 0.01% | +25.0% |
| Q3 2022 | $5,710,000 | -36.3% | 200,500 | +1.3% | 0.00% | -33.3% |
| Q2 2022 | $8,960,000 | -65.1% | 198,000 | -41.3% | 0.01% | -57.1% |
| Q1 2022 | $25,653,000 | -41.1% | 337,224 | +15.2% | 0.01% | -46.2% |
| Q4 2021 | $43,589,000 | +2.1% | 292,624 | -0.2% | 0.03% | -3.7% |
| Q3 2021 | $42,688,000 | -26.9% | 293,224 | -1.7% | 0.03% | -25.0% |
| Q2 2021 | $58,418,000 | +30.9% | 298,324 | +21.0% | 0.04% | +20.0% |
| Q1 2021 | $44,635,000 | +35.9% | 246,600 | +6.3% | 0.03% | +30.4% |
| Q4 2020 | $32,837,000 | – | 231,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |